In Brief: Pharmacia & Upjohn
This article was originally published in The Gray Sheet
Executive Summary
Pharmacia & Upjohn: Announces U.S. launch of its CeeOn Model 920 foldable intraocular lens for use in cataract surgery. The Model 920, the first of a class of IOLs planned under the CeeOn brand name, "provides optical advantages in clarity and finish, has the pliability needed for folding and implantations and addresses the surgical trend towards less invasive surgery with smaller incisions," according to the company. Approved by FDA in May via premarket approval application supplement, the Model 920 has been available in Europe since the fall of 1995...
You may also be interested in...
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.